Literature DB >> 21485124

[Tricyclic antidepressant overdose rescued by percutanenous cardiopulmonary support: report of two cases].

Kaori Kobayashi1, Mamoru Miyajima, Toshiharu Tanaka, Ken Kumagai, Yasuo Hirose, Yasushi Hori, Hidenori Kinoshita.   

Abstract

We report the case of two patients tricyclic antidepressant (TCA) overdoses complicated with severe circulatory failure, successfully resuscitated using percutaneous cardiopulmonary support (PCPS). In case 1, a woman transferred to our emergency department, presented with severe circulatory failure and developed cardiopulmonary arrest. She received prolonged cardiopulmonary resuscitation, and initiated with PCPS. In case 2, a woman presented our emergency department on foot. 3 hours after admission, she falled into severe circulatory failure with polymorphic ventricular tachycardia, and PCPS was started. TCA remains widely used despite its dangerous cardiovascular and neurological effects in overdosed patients. The most common cause of death after TCA overdose is cardiovascular toxicities. In current guidelines, cardiopulmonary resuscitation with extracorporeal cardiopulmonary bypass may be particularly effective for these patients to have a reversible etiology without preceding multisystem organ failure. Cardiotoxicities in TCA overdose are reversible and extracorporeal cardiopulmonary support should be promptly considered in refractory arrhythmia and hypotension despite conventional advanced life support.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21485124

Source DB:  PubMed          Journal:  Chudoku Kenkyu        ISSN: 0914-3777


  2 in total

1.  Survival after severe amitriptyline poisoning with prolonged ventricular tachycardia and cardiac arrest.

Authors:  Dayakshi D K Abeyaratne; Chathuri Liyanapathirana; Anushka Gamage; Piyumanthi Karunarathne; Medhini Botheju; Jegarajah Indrakumar
Journal:  BMC Res Notes       Date:  2016-03-15

2.  ST-T segment changes in patients with tricyclic antidepressant poisoning.

Authors:  Farzad Gheshlaghi; Mozhgan Karbalayi Mehrizi; Ahmad Yaraghi; Ali Mohammad Sabzghabaee; Forough Soltaninejad; Nastaran Eizadi-Mood
Journal:  J Res Pharm Pract       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.